False Claims Act Settlements and Judgments Exceed $2.9B in Fiscal Year 2024

DOJ press release (15 Jan 2025) on FY2024 FCA recoveries: exceeding $2.9 billion; 558 settlements and judgments (and FY2023 restated as a record 566); record 979 qui tam suits ("more than 18 new cases every week", average, not recorded); more than $78 billion since 1986; health care over $1.67 billion; relator typically 15-30%; qui tam recoveries exceeding $2.4 billion; relator shares exceeding $400 million; pandemic fraud more than 250 settlements/judgments exceeding $250 million; MSO kickbacks over $53 million and 48 physicians to date; AECOM Katrina applications over $25 million combined; credit for cooperation and self-disclosure (no numbers); post-FY-end Teva $425 million + $25 million (10 Oct 2024) and Raytheon $428 million (16 Oct 2024), not in the total. Named matters, none linked to a qui tam suit or relator in this release (not cases): Endo $475.6 million allowed claim, Rite Aid $7.5 million + $401.8 million claim (its intervened whistleblower suit appears in the FY2023 release), Dr. Gerber $4.7 million, Crossroads $863,934, Grand Health Care $21.3 million, Acadia $16.6 million, Daniel Hurt over $27 million, Oak Street Health $60 million, continuing Medicare Advantage suits, Community Health Network $345 million, DaVita $34.5 million, Thekkek/Paksn $45.6 million, RDx $10.3 million, Innovasis $12 million, Erlanger suit, Nassenstein suit, Rite Aid/Elixir $101 million + $20 million claim, Walgreens $106.8 million, Silver Lake over $30 million, Gentiva $19.4 million, Regeneron suit, six USFHP plans suit and Kennell $779,951, Sikorsky/Derco $70 million, Austal $811,259, Insect Shield suit, Kabbage up to $120 million claim, West Coast Dental $6.3 million, Hemisphere GNSS $2.6 million, Capstone/Maloney $14.3 million, Provista $26.3 million default judgment, CityMD $12 million, Georgia Tech suit, Guidehouse $7.6 million, Nan McKay $3.7 million, Insight Global $2.7 million, Gen Digital $55.1 million, City of Los Angeles $38.2 million, Hilcorp $34.6 million, XTO $16 million, Hahn Air $26.8 million, Consolidated Nuclear Security $18.4 million, AECOM $11.8 million. Three sidebar teasers at the end (GS Foods, BioReference, Unified Care) are other releases, not part of this one. Already in the data: 6 observations. Added: 2 rules, 7 observations. Decision 10 pass (2026-10-10): every named settlement, judgment and newly announced government suit not already in cases.csv added as a case with whistleblower_link=not_stated (the document does not tie it to a whistleblower): 45 cases (35 settlements, 4 judgments (outcome 'reported'), 6 pending government suits or claims). Amounts as printed (lower/upper bounds and global vs civil parts explained in notes); individuals only where named by the agency as parties. Not recorded as cases: 'more than 250' pandemic settlements (over $250 million), MSO settlements with 48 physicians (over $53 million) and the 'over $25 million' combined AECOM-related recoveries (aggregates), and repeat mentions of continuing litigation against UnitedHealth, Elevance and Kaiser. Teva ($425 million and $25 million, 10 Oct 2024) and Raytheon (16 Oct 2024) are recorded with their dates though outside the FY2024 total.